/Companies

Essenvia

Woodland Hills, US · Founded 2020 · Delaware corporation · 7 known investors

Find your way into Essenvia

Sign up to see every warm intro you have to Essenvia

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Essenvia team. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Essenvia offers a regulatory information management platform for medical device regulatory affairs teams, automating submissions (including FDA eSTAR), centralizing registrations, and providing AI-driven regulatory intelligence and lifecycle tracking. It integrates with existing systems such as PLM, eQMS, and ERP and supports compliance frameworks including SOC 2, GxP, 21 CFR Part 11, and GDPR.

Founders & leadership

BS
Basant SahooCo-founder & CTOHe previously led data science work as an associate director at WNS Global Services and served as business analysis manager and data scientist at GSN Games, following roles at Goldman Sachs, Karvy Capital, and AXA UK. His earlier career included application development and quantitative analysis, with an internship at Standard Chartered Bank.
SMSoumya Mahapatra
Soumya MahapatraCo-founder & CEOBefore starting Essenvia in 2019, he spent nearly a decade at Cognizant, rising from senior associate to associate director, with earlier engineering and systems roles at Infosys and UST Global. He completed the Founder Institute program in 2018.

Investors · 7

Reported raises · per SEC filings

Form D private placements

$5.5M disclosed across 1 round · 2023

▶$5.5MraisedMar 2023 · 34 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Basant SahooDirector
  • Soumya MahapatraExecutive Officer, Director
Offering amount
$5.5M
Amount sold
$5.5M
First sale
Mar 2023
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 2

Companies working in the same space as Essenvia.

In the news

Frequently asked questions

What does Essenvia do?
Essenvia offers a regulatory information management platform for medical device regulatory affairs teams, automating submissions (including FDA eSTAR), centralizing registrations, and providing AI-driven regulatory intelligence and lifecycle tracking. It integrates with existing systems such as PLM, eQMS, and ERP and supports compliance frameworks including SOC 2, GxP, 21 CFR Part 11, and GDPR.
Who are Essenvia's investors?
Essenvia's investors include Arka Venture Labs, Core91.vc, Expert DOJO, Rebright Partners, Benhamou Global Ventures, BioGeneration Ventures, Wavemaker Three-Sixty Health.
How much funding has Essenvia raised?
Essenvia has disclosed $5.5M raised across 1 round.
Where is Essenvia headquartered?
Essenvia is headquartered in Woodland Hills, US.